openPR Logo
Press release

Onychomycosis Treatment Market Assessment 2018 - 2028 | Novartis AG, Galderma S.A., Valeant Pharmaceuticals, Inc., Johnson & Johnson Services, Pfizer, Inc.

01-30-2019 12:53 PM CET | Health & Medicine

Press release from: Future Market Insights

Onychomycosis Treatment Market Assessment 2018 - 2028 |

Accounting for approximately 12% of the entire fungal infection treatments space, onychomycosis treatment has been witnessing a high prevalence-low awareness scenario over the years. However, gradually increasing awareness about the potential threats of onychomycosis and growing availability of treatments for the condition clearly point to a promising outlook for onychomycosis treatment market over the course of coming years.

The roughly US$ 4.5 billion global market for onychomycosis treatment is slated to observe robust year on year revenue growth of 6.4% in 2019. A new market research study by Future Market Insights throws light on the increasing role of combination therapy recommendations in supporting demand growth of onychomycosis treatment, in the near future.

Request to View a Sample Copy of This Report @

Drugs Remain a Favored Choice of Treatment for Onychomycosis

While the line of treatment for onychomycosis is diverse, drugs remain the first line of onychomycosis treatment – with over 80% market value share - owing to consistently high success rate, says the report.

High treatment penetration of topical products is a major highlight of the global onychomycosis treatment market report.

Drugs, alone represent between 40-50% success rate, whereas rise up to an even higher success rate - in combination with photodynamic therapy.

The lower price point compared to high-end photodynamic or laser therapy is projected to boost patient preference for drugs in onychomycosis treatment.

Growing Inclination towards Combination Therapy to Boost Nail Lacquer Sales

With bolstering recommendations for combination therapy by both podiatrists and dermatologists is cited as another strong factor encouraging the demand for onychomycosis treatment worldwide.

Research indicates an increased cure rate when the treatment combines systemic and topical therapies, which is presumably stimulating onychomycosis patients to opt for treatment that involves long-term antifungal drugs medication, followed by application of nail lacquers.

A senior market research analyst at FMI explains, “Oral terbinafine has been a popular choice for including in the combination therapy over the years, which is followed by amorolfine nail lacquer in follow-up sessions. The emergence of more such combination therapies as a part of onychomycosis treatment is likely to support the growth of onychomycosis treatment market in coming years”.

Nearly 80% Revenue Belongs to Distal Subungal Onychomychosis Treatment

Distal subungal onychomycosis, though is the most prevalent disease indication pushing the demand for treatment with almost 80% share in the total market value, the report projects that the prevalence of proximal subungal onychomycosis would increase at a significant rate in coming years.

North America & Western Europe Bag in over 70% Market Value Share

Holding a collective revenue share of more than 70%, North American and Western European markets for onychomycosis treatment continue to provide the strongest push to market growth.

In addition to the highest onychomycosis prevalence, North America’s landscape reaps a major advantage of favorable reimbursement scenario in the US.

Get Report Customization Now @

Analysis of the Moderately Consolidated Market Structure

Among the top performers in the global onychomycosis treatment landscape including Novartis AG, Galderma S.A., Valeant Pharmaceuticals, Inc., Johnson & Johnson Services, Pfizer, Inc., and others, the top five companies account for a global market share of over 43% - leaving the market as a moderately consolidated landscape. With an objective to achieve impactful product promotion campaigns, companies are signing sales and marketing agreements, according to the report.

As indicated by recent research data, Valeant’s Jublia and Pfizer’s Diflucan have been the key brands responsible for sizable revenue generation in the onychomycosis treatment marketplace.

Jublia continues to enjoy booming sales through the company’s D2C (direct-to-consumer) marketing strategy. Galderma’s Loceryl and Novartis’ Lamisil are also projected to retain higher attractiveness in the onychomycosis treatment landscape.

The leading market players are likely to maintain their strategic focus on a strong sales channel and a versatile distribution network.

Strategic partnerships and collaborations are foreseen to be significant developmental decisions of established brands in the landscape of onychomycosis treatment.

Acquisitions are also trending the competitive landscape of onychomycosis treatment market, and one of the recent acquisitions includes acquisition of the UK based Ziarco Group Limited by Novartis, which is likely to influence the novel treatment development scenario in the dermatology space.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705



This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Onychomycosis Treatment Market Assessment 2018 - 2028 | Novartis AG, Galderma S.A., Valeant Pharmaceuticals, Inc., Johnson & Johnson Services, Pfizer, Inc. here

News-ID: 1546158 • Views: 190

More Releases from Future Market Insights

Hormone Replacement Therapy Market COVID-19 Impact and Global Analysis by Produc …
Hormone Replacement Therapy is any form of hormone therapy where in the patient, in course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Menopause, is the time in most women's lives when menstrual periods stop permanently, and the woman is no longer able to have children. Menopause typically occurs between 45 and 55 years of age.
Critical Care Information Systems Market Key Players- Affiliated Computer Servic …
Critical care information systems are used to help manage the large amount of data generated in an intensive care unit every day. Obtaining, synchronizing, assimilating, and evaluating patient data is very difficult because of incompatibilities among monitoring equipment, the absence of standard data formatting and proprietary limitations from industry. The intensive care units are a specialized section of a hospital containing the equipment, medical and nursing staff, monitoring and life
Paper Cores Demand Catalyzes amid High Emphasis on Circular Economy: FMI Study
The global packaging industry has made remarkable progress in recent years, with numerous innovations and technological advances prioritized. Particular emphasis is placed on ensuring sustainability and the spread of the circular economy. Reliable benefits have been obtained in reducing the generation of municipal solid waste. Future Market Insights is a recently published research report that incorporates historical analysis from 2015 to 2019 and future assessments from 2020 to 2030 to
Endometrial Cancer Treatment Market Key Players- R-Pharm-US LLC., Bristol-Myers …
Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options.

All 5 Releases

More Releases for Treatment

What if we are all part of the solution and not part of the pollution, what if we lived in a world that is less polluted because the amount of waste generated are properly treated before disposal, what if we had clean and clear water made available for everyone? These and many what ifs we can ask ourselves.Billions of tonnes of waste are been produced annually with about 42 million
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Rotator Cuff Tendinopathy Treatment
If you are suffering from rotator cuff tendinopathy, the tendon collagen in the rotator cuff of the shoulder has degenerated. This degeneration can cause chronic weakness, pain, limited range of motion and inflammation. While the breakdown of collagen can’t be reversed, the progression and symptoms of the condition can be managed through a combination of modalities. DIAGNOSIS Before treatment, you need an orthopedic doctor to diagnose the condition. Your doctor would begin by
Deep Wrinkle FOld Treatment
Feel that you look older than your age? Your face always seems to be having a sad look? These are mainly due to deep wrinkles and folds that develop over time on our face due to ageing of the bone, muscle, ligaments and fat loss on our face. Nasolabial Fold: (Nose to lip corner) Some lines in this area are natural, but as they get deeper, the skin folds over and makes the face
Vitamin Deficiency Treatment Market
Undernourishment in the underdeveloped countries is the major driver of growth of global vitamin deficiency treatment market. High incidence of anemia, paraesthesia and other hypovitaminosis are the other major factors contributing to hike in global vitamin deficiency treatment market. Vitamin supplements are also used as an adjunct therapy in many disorders including alopecia, depression, ulcers etc., high prevalence of which can propel the growth of global vitamin deficiency treatment market.
Global Sinusitis Treatment Market
Factors contributing for growth of sinusitis treatment market are demand for diagnostic test and antibiotics, patient education programs by companies and hospitals for increasing awareness among the public. Advancement in technology, myriad of people suffering from common cold and no age specific are additional factors that will drive the market over the forecasted period. Though the sinusitis treatment market is expected to generate significant revenue throughout the forecast period, the